To evaluate the prognostic power of the DMEGs in “EGFR Wild Type/Low PD-L1 expression” NSCLC, we constructed a DMEG-based prognostic model using LASSO regression. This evidence concerns the gene EGFR and non-small cell lung carcinoma.